We also found that the combination of PTX and low-dose IR780 may have potential sensitization effects via the PI3K/Akt pathway, which would be conducive to reversing tumor resistance to PTX; however, further experimental verification is needed to explore this aspect of treatment. Here, AKT1 is linked to neoplasm.